Jiangsu Chia Tai Tianqing presents new exportin-1 receptor antagonists

May 19, 2023

Jiangsu Chia Tai Tianqing Pharmaceutical Group Co. Ltd. has divulged exportin-1 (CRM1; XPO1) receptor antagonists reported to be useful for the treatment of lymphoma and leukemia.

BioWorld Science Cancer Patents

Today's news in brief

BioWorld

BioWorld briefs for Nov. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Nov. 11, 2025.

Illustration of magnifying glass inspecting brain

Anchoring, and bootstrapping, psychiatry into the precision medicine era

BioWorld Science

Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...

UK launches strategy to replace animals in research as scientists voice concern

BioWorld

The U.K. government has published a road map for phasing out animal testing in life sciences research and announced £75 million (US$98.6 million) for work to...

Lilly moves deeper into RNAi with $1.2B Sanegene obesity deal

BioWorld

In a deal worth $1.2 billion, Suzhou Sanegene Bio Inc. and Eli Lilly and Co. are partnering to advance RNAi candidates for metabolic diseases based on Sanegene's...